
Peter A. Hruskoci
Examiner (ID: 10260)
| Most Active Art Unit | 1724 |
| Art Unit(s) | 1778, 1724, 1776, 1723, 2899, 1306, 1308, 1801, 1797, 3307 |
| Total Applications | 2898 |
| Issued Applications | 2282 |
| Pending Applications | 120 |
| Abandoned Applications | 496 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16451060
[patent_doc_number] => 20200360486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC COMPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/823493
[patent_app_country] => US
[patent_app_date] => 2020-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823493
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/823493 | Pharmaceutical composition for preventing or treating diabetic complications | Mar 18, 2020 | Issued |
Array
(
[id] => 19327010
[patent_doc_number] => 12044687
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-07-23
[patent_title] => Method of detecting cellular reporting for therapy production
[patent_app_type] => utility
[patent_app_number] => 16/818441
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8385
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818441
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818441 | Method of detecting cellular reporting for therapy production | Mar 12, 2020 | Issued |
Array
(
[id] => 17875554
[patent_doc_number] => 11447555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies
[patent_app_type] => utility
[patent_app_number] => 16/815250
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 21
[patent_no_of_words] => 29583
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16815250
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/815250 | Methods for treating type 1 diabetes using glucagon receptor antagonistic antibodies | Mar 10, 2020 | Issued |
Array
(
[id] => 17193342
[patent_doc_number] => 11162085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Methods for treating anemia in a subject in need thereof
[patent_app_type] => utility
[patent_app_number] => 16/808010
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27954
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808010 | Methods for treating anemia in a subject in need thereof | Mar 2, 2020 | Issued |
Array
(
[id] => 17193342
[patent_doc_number] => 11162085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Methods for treating anemia in a subject in need thereof
[patent_app_type] => utility
[patent_app_number] => 16/808010
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27954
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808010 | Methods for treating anemia in a subject in need thereof | Mar 2, 2020 | Issued |
Array
(
[id] => 17193342
[patent_doc_number] => 11162085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Methods for treating anemia in a subject in need thereof
[patent_app_type] => utility
[patent_app_number] => 16/808010
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27954
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808010 | Methods for treating anemia in a subject in need thereof | Mar 2, 2020 | Issued |
Array
(
[id] => 17193342
[patent_doc_number] => 11162085
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Methods for treating anemia in a subject in need thereof
[patent_app_type] => utility
[patent_app_number] => 16/808010
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 27954
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16808010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/808010 | Methods for treating anemia in a subject in need thereof | Mar 2, 2020 | Issued |
Array
(
[id] => 16429465
[patent_doc_number] => 10829532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
[patent_app_type] => utility
[patent_app_number] => 16/795021
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 31262
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795021
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795021 | Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels | Feb 18, 2020 | Issued |
Array
(
[id] => 16012751
[patent_doc_number] => 20200181218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS
[patent_app_type] => utility
[patent_app_number] => 16/795026
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31229
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795026
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795026 | Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels | Feb 18, 2020 | Issued |
Array
(
[id] => 16091119
[patent_doc_number] => 20200199546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => ISOLATED GDF TRAP POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/795076
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795076 | ISOLATED GDF TRAP POLYPEPTIDE | Feb 18, 2020 | Abandoned |
Array
(
[id] => 16564267
[patent_doc_number] => 10889626
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-12
[patent_title] => Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
[patent_app_type] => utility
[patent_app_number] => 16/795015
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 31242
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795015
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795015 | Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels | Feb 18, 2020 | Issued |
Array
(
[id] => 16112203
[patent_doc_number] => 20200208124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => ISOLATED GDF TRAP POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/795083
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795083 | Methods for treating anemia in a subject in need thereof | Feb 18, 2020 | Issued |
Array
(
[id] => 16112203
[patent_doc_number] => 20200208124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => ISOLATED GDF TRAP POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/795083
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795083 | Methods for treating anemia in a subject in need thereof | Feb 18, 2020 | Issued |
Array
(
[id] => 16112203
[patent_doc_number] => 20200208124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => ISOLATED GDF TRAP POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/795083
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795083 | Methods for treating anemia in a subject in need thereof | Feb 18, 2020 | Issued |
Array
(
[id] => 16091121
[patent_doc_number] => 20200199547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => ISOLATED GDF TRAP POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/795088
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27978
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795088
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795088 | Methods for treating anemia in a subject in need thereof | Feb 18, 2020 | Issued |
Array
(
[id] => 16112203
[patent_doc_number] => 20200208124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => ISOLATED GDF TRAP POLYPEPTIDE
[patent_app_type] => utility
[patent_app_number] => 16/795083
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27970
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795083 | Methods for treating anemia in a subject in need thereof | Feb 18, 2020 | Issued |
Array
(
[id] => 15928031
[patent_doc_number] => 20200155649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING OBESITY AND HYPERPHAGIA
[patent_app_type] => utility
[patent_app_number] => 16/781304
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16168
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16781304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/781304 | Compositions and methods for treating obesity and hyperphagia | Feb 3, 2020 | Issued |
Array
(
[id] => 16175541
[patent_doc_number] => 20200222509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHT
[patent_app_type] => utility
[patent_app_number] => 16/752386
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752386
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/752386 | METHODS FOR TREATING DIABETES AND REDUCING BODY WEIGHT | Jan 23, 2020 | Abandoned |
Array
(
[id] => 16452580
[patent_doc_number] => 20200362006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
[patent_app_type] => utility
[patent_app_number] => 16/751538
[patent_app_country] => US
[patent_app_date] => 2020-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54669
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16751538
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/751538 | Engineered polypeptides having enhanced duration of action | Jan 23, 2020 | Issued |
Array
(
[id] => 16523610
[patent_doc_number] => 20200397690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c
[patent_app_type] => utility
[patent_app_number] => 16/750432
[patent_app_country] => US
[patent_app_date] => 2020-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16750432
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/750432 | THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c | Jan 22, 2020 | Abandoned |